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Uterine myomas are the main cause for gynecological disease in premenopausal women. If a myomec-
tomy is indicated, abdominal myomectomy is still a frequently performed procedure although laparo-
scopic myomectomy should be the method of choice. Searches were conducted in PubMed and The
Cochrane Library to identify relevant literature. Compared with myomectomy by laparotomy and min-
ilaparotomy, laparoscopic myomectomy is associated with improved short-term outcomes. Laparoscopy
is further associated with less adhesion formation. Pregnancy rates after myomectomy in symptomatic
patients might be higher after laparoscopy than after laparotomy. Although uterine ruptures following
laparoscopic myomectomy are described in the literature, it seems to be a rare event. Concerning the
recurrence, there is evidence that rates are similar after laparoscopy and laparotomy. Myomectomy by
laparoscopy has several advantages over abdominal myomectomy (by conventional laparotomy and
minilaparotomy) and should be the standard procedure. Despite the advantages of laparoscopy,
abdominal myomectomy is still a frequently performed procedure. Lack of training in advanced lapa-
roscopic procedures hampers the widespread use of laparoscopic myomectomy. Due to the advantages of
laparoscopic surgery, efforts should be made to implement this procedure into daily practice. To provide
the best care, physicians should offer patients the opportunity of a laparoscopic treatment of myomas.
Copyright  2014, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
The most common benign tumor of the uterus in women of
reproductive age is the uterine leiomyoma (uterine ﬁbroid, ﬁbroid,
myoma).1 In a large ultrasonographic study, the cumulative inci-
dence of uterine myomas by age 50 years was over 80% for black
women and nearly 70% for white women.2 Although not all women
with myomas develop symptoms, myomas have a great clinical
impact.3,4 The majority of hysterectomies are performed due to
symptomatic uterine myomas.5,6 Symptoms include abnormal
uterine bleeding, pelvic pressure and pain, and reproductive
dysfunction.3 If a future pregnancy is desired or if women want to
preserve their uterus for personal reasons, an appropriate alter-
native to hysterectomy has to be found for their treatment.
Abdominal myomectomy has been performed routinely for
many decades, in recent years, various minimally invasivets of interest relevant to this
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for Gynecologic Endoscopy and Minimalternatives to laparotomy have been developed.7 At present, a vast
number of minimally invasive approaches for the treatment of
myomas exist including abdominal myomectomy (by mini-
laparotomy8 or ultraminilaparotomy9), vaginal myomectomy,10
laparoscopic myomectomy (also gasless laparoscopy,11 single ac-
cess laparoscopy,12 or robotic assisted laparoscopy13), uterine artery
embolization (UAE),14 uterine artery occlusion,15 myolysis,16 mag-
netic resonance imaging-guided focused ultrasound,17 and medical
treatment.18 Only a few of the treatment options are investigated in
randomized, controlled trials and some of them still need to be
investigated for safety and efﬁcacy. This article focuses on myo-
mectomy as the most common plastic and reconstructive uterine
procedure. Myomectomy by laparoscopy is compared to myomec-
tomy by laparotomy, minilaparotomy and robotic assisted laparo-
scopic myomectomy. Moreover, frequent concerns associated with
laparoscopic myomectomy are discussed.Materials and methods
The PubMed database was searched using the search term
“myomectomy” alone and in combination with “adhesions”,
“infertility OR fertility outcome”, “uterus rupture”, “recurrence”,
“costs”, and “surveys” with the limitation on articles published inally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 2. The myometrium overlying the myoma is opened and the myoma is visible. A
myomascrew is inserted into the myoma.
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searched using the search term “laparoscopy and learning curve”.
The Cochrane Library was also searched for the search term
“myomectomy”. Articles were included in the review if the title
indicated any relevance to the topic. Statements in the articles were
scrutinized by searching the corresponding articles listed in the
references sections. The reference lists were also searched for
relevant literature.
Results and discussion
Myomectomy
Depending on the preference of the surgeon, different modiﬁ-
cations of the technique are possible, concerning trocar placement,
instruments used, methods to reduce bleeding, or suture material
used. The following section provides a brief overview of the basic
steps of myomectomy.19,20
During the procedure, the use of a uterus manipulator facilitates
myomectomy and suturing as it enables the positioning of the
uterus depending on the location of the myoma (Fig. 1). At the
beginning of the procedure, diluted vasopressin is injected between
the myoma capsule and the normal muscle layer which is an
effective technique to reduce hemorrhage.21 Although rare, some
severe complications, associated with the use of vasopressin, were
reported including pulmonary oedema, severe hypotension, and
bradycardia with eventual cardiac arrest.22 Therefore, the possible
occurrence of these complications should be kept in mind when
diluted vasopressin is used. After injection, the myometrium
overlying the myoma become pale and the myometrium can be
incised in a horizontal or vertical direction. A horizontal incision
may facilitate the subsequent suturing of the myometrial defect.23
To further reduce the risk of bleeding, the incision is made with a
monopolar instrument (hook or scissors) or a harmonic scalpel.1,23
Once the myoma pseudocapsule is reached, the myoma can be
grasped with a forceps or a myoma screw, enabling traction and
countertraction on the myoma which is necessary for the enucle-
ation (Fig. 2). If the myoma is enucleated along the avascular
cleavage plane, the enucleation should be easily possible. Attach-
ments to the myometrium can be lysed with bipolar forceps or
monopolar scissors.19 The enucleated myoma is temporarily placed
in the cul-de-sac and is removed at the end of the procedure by
mechanical or electric morcellation. Suturing of the myometrialFig. 1. Fundal myoma.defect is of great importance for the strength of the uterine scar.
Depending on the depth of the defect, a single or multilayer closure
is necessary to minimize the risk of hematoma, postoperative
bleeding, or uterine rupture in subsequent pregnancies (Fig. 3).22,23
Laparoscopic myomectomy versus abdominal myomectomy by
conventional laparotomy
The ﬁrst reports of abdominal myomectomy as an alternative to
hysterectomy were published over 100 years ago.24,25 Back then,
reasons for uterus preservation already included the woman’s
desire for future childbearing as well as thewoman’s wish for organ
preservation in order to avoid emotional distress caused by the
experience of an organ loss.26,27 Despite these early advocacies for
myomectomy, it took decades before abdominal myomectomy was
generally accepted as a treatment option for uterine ﬁbroids.28,29
Additionally, in 1979, Semm30 introduced the laparoscopic myo-
mectomy as a promising new surgical approach for the treatment of
uterine myomas. Since then, numerous articles have been pub-
lished concerning the feasibility and safety of laparoscopic myo-
mectomy.31e33 However, only a few studies compared laparoscopicFig. 3. Uterus after myomectomy with hysterectomy suture.
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them are prospective, randomized trials.34e38 The retrospective
trials revealed that laparoscopic myomectomy is associated with
lower hemoglobin drop or less blood loss, respectively, lower
morbidity, and a shorter hospital stay.34,35 These ﬁndings are in line
with the prospective, randomized studies (Table 1).36e38 Moreover,
Holzer et al38 demonstrated in a double-blind study that laparo-
scopic myomectomy is associated with lower postoperative pain. In
recent years, however, publications about myomectomy by mini-
laparotomy as a minimally invasive alternative to conventional
laparotomy are increasing. Prospective, randomized studies exist,
comparing myomectomy by laparoscopy and minilaparotomy.
Therefore, the next section provides a more detailed comparison of
these two minimally invasive ﬁbroid treatments.
Laparoscopic myomectomy versus abdominal myomectomy by
minilaparotomy
Minilaparotomy is a modiﬁcation of laparotomy where the skin
incision does not exceed 5e6 cm.8,39 Althoughminilaparotomywas
already described in the 1990s 40, only in the past decade, an
increasing number of articles have been published concerning
minilaparotomy as a minimally invasive treatment option for
myomectomy.8,41,42 Authors, who encourage myomectomy by
minilaparotomy, state that this procedure has several advantages
over laparoscopic myomectomy including the ability to palpate the
uterus, the possibility to operate large myomas, and no need for
extra equipment and/or advanced technical skills, especially in
suturing the uterine incision.8,43 In comparison with conventional
laparotomy, minilaparotomy showed advantages of minimally
invasive surgery such as a shorter hospital stay.44,45 However,
prospective, randomized trials comparing minilaparotomy and
laparoscopy, conﬁrmed that laparoscopy is associated with better
short-term outcomes such as a signiﬁcantly lower decline in he-
moglobin concentrations, lower postoperative pain, lower anal-
gesic requirements, and a shorter hospital stay (Table 2).39,46,47
Concerning complications associated with laparoscopic and
abdominal myomectomy, Alessandri et al46 reported in their study
one laparoconversion due to difﬁculties of hemostasis and one case
of diffuse peritonitis caused by ileal perforation in the laparoscopic
group. Interestingly, in the study of Palomba et al47 six lapa-
roconversions occurred in the minilaparotomy group. TheseTable 1
Laparoscopic myomectomy versus abdominal myomectomy by conventional laparotomy
LM versus AM Mais et al 199636 S
No. of patients 20 versus 20 6
No. of myomas 2.5  1.1 versus 2.3  0.8 2
Diameter of the
largest myoma (cm)
4.4  0.8 versus 4.7  1.3 7
Operative time (min) 100  31 versus 93  27 1
Estimated blood loss (mL) 200  50 versus 230  44 d
Decline in Hb
concentration
d 1
Complications/
postoperative outcome
Fever: 1/20 versus 1/20 F
Postoperative pain
assessed by visual
analog scale (VAS)
Signiﬁcantly lower in the LM
group (ﬁgures are represented
in a chart)
d
Analgesic-free patients
at Day 2 (%)
85 versus 15 d
Piritramid boli ﬁrst 24 h d d
Time to discharge/length
of hospital stay
90 versus 10
patients discharged by Day 3 (%)
7
Recuperation/return to work 90 versus 5
patients fully recuperated by Day 15 (%)
d
Values are expressed as mean  SD or median (range). First value ¼ laparoscopic myomlaparoconversions were due to posterior isthmic and infraliga-
mentary location of the leiomyomas and the authors mentioned
that in these cases the degree of surgical difﬁculty was similar to
that of laparoscopy. In this study, location of the main myoma
rather than the size of the myoma was the main factor that inﬂu-
enced the results. The authors stated that myomectomy of anterior,
fundal, and lateral myomas was simpler and faster when mini-
laparotomy was conducted. However, there were ﬁve (7.4%) post-
operative complications in the minilaparotomy group including
one case of fever >38C, two cases of wound infections, and one
case of wound dehiscence. In the laparoscopic group, two (2.9%)
postoperative complications occurred including one case of fever
>38C and one case of urinary tract infection.47 Cicinelli et al39
reported two intraoperative complications in the laparoscopic
group. In one patient, moderate subcutaneous emphysema devel-
oped at pneumoperitoneum creation and in the other patient the
procedure was converted to minilaparotomy due to difﬁculty in
reconstructing the uterine wall. Postoperatively, ﬁve patients in the
laparoscopy group (12.5%) and 10 patients in the minilaparotomy
group (25%) developed fever.39 Compared with myomectomy by
minilaparotomy, laparoscopic myomectomy is associated with
better short-term outcomes. Furthermore, laparoscopic myomec-
tomy carries a low risk of minor and major complications.
Laparoscopic myomectomy versus robotic-assisted laparoscopic
myomectomy
In the past decade, robotic surgery has been introduced in gy-
necology and is described as “an enhancement along the contin-
uum of laparoscopic technological advances”.13 Robotic surgery
provides a 3-dimensional image, absence of tremor, superior in-
strument articulation, comfort for the surgeon, and a faster learning
curve.48 At present, only retrospective studies are available
comparing robotic-assisted laparoscopic myomectomy (RALM)
with laparotomy or laparoscopy. Compared with laparotomy, RALM
is associated with a decrease in blood loss, fewer complications,
and a shorter hospital stay.49e51 Compared with laparoscopic
myomectomy, RALM seems to have similar short-term out-
comes.51e53 Furthermore, Nezhat et al53 stated that RALM does not
offer any major advantages over laparoscopy when laparoscopy is
performed by a skilled surgeon. However, removal of large, unfa-
vorable localized myomas as well as suturing the uterine incision is.
eracchioli et al 200037 Holzer et al 200638
6 versus 65 19 versus 21
.94  1.53 versus 2.75  1.98 2 (1e4) versus 3 (1e7)
.07  2.54 versus 7.47  2.60 7 (4e10) versus 5 (3e11)
00.23  38.34 versus 88.85  26.91 99  37 versus 68  22
71  80 versus 115  64
.33  1.23 versus 2.17  1.57 d
ever: 8 (12.1%) versus 17 (26.2%)
Transfusions: 0/66 versus 3/65
None
2.28  1.38 versus 4.30  1.63
(mean overall VAS e score at
24 h, 48 h, and 72 h postoperatively)
d
7 (0e23) versus 12 (2e90)
5.61  37.09 versus 142.80  34.60
Length of hospital stay (h)
d
2.9  1.8 versus 3.7  2.9
Return to work (wk)
ectomy (LM). Second value ¼ myomectomy by conventional laparotomy (AM).
Table 2
Laparoscopic myomectomy versus abdominal myomectomy by minilaparotomy.
LM versus MLT Alessandri et al 200646 Palomba et al 200747 Cicinelli et al 200939
No. of patients 74 versus 74 68 versus 68 40 versus 40
No. of myomas 2.6  1.0 versus 2.8  1.0 1 (1e3) versus 1 (1e3) 2.1  0.3 versus 2.0  0.4
Diameter of the largest myoma (cm) 6.2  0.7 versus 6.4  0.5 7.6 (5.7e9.8) versus 7.8 (5.5e9.7) 5.2  1 versus 4.8  1.1
Operative time (min) 98  13 versus 85  14 108 (69e150) versus 95 (62e174) 80  23 versus 71  18
Estimated blood loss (mL) d 130 (90e200) versus 160 (90e280) 133  29 versus 186  44
Decline in Hb concentration (g/dL) 1.1  0.5 versus 2.2  0.5 0.8 (0.2e2.1) versus 1.3 (0.2e2.5) 1.5  0.4 versus 2.5  0.3
Complications 2/74 versus 0/74 Laparoconversion: 0/68 versus 6/68
Postop. complications: 2/68 versus 5/68
Intraop. complications: 2/40 versus 0/40
Fever: 5/40 versus 10/40
Postoperative pain assessed by visual
analog scale (VAS)
4.1  1.5 versus 6.5  1.5
(6 h after surgery)
d d
Time of postoperative ileus (h) 28  6 versus 45  6 24 (24e72) versus 24 (24e72) 18  7 versus 31  6
Request for analgesic (%) 34 versus 73 (in the ﬁrst 24 h
after operation)
d d
Vials of analgesic used (n) d 3 (1e8) versus 7 (2e10) d
Time to discharge/length of hospital stay 38  12 versus 48  12
Time to discharge (h)
2 (2e5) versus 3 (3e5)
Length of hospital stay (d)
2.1  0.6 versus 3.3  0.5
Length of hospital stay (d)
Recuperation/return to work 90.3 versus 74.3
patients fully recuperated
by Day 15 (%)
5 (3e11) versus 5 (3e12)
Return to work (d)
d
Values are expressed as mean  SD or as median (range). First value ¼ laparoscopic myomectomy (LM). Second value ¼ myomectomy by minilaparotomy (MLT).
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adoption of laparoscopy.49,54 Although robotic surgery can over-
come these difﬁculties,51,55 the higher costs currently lead to an
obvious drawback of this possible approach.49,56 In case of per-
sisting higher costs, robotic surgery is unlikely to be adopted by all
hospitals in the near future. At present, therefore, laparoscopy re-
mains the preferred approach if myomectomy should be conducted
by a minimally invasive approach.
Postoperative adhesions
Adhesions are ﬁbrin strands between two anatomical sites
which are normally not attached to each other. After a previous
laparotomy, adhesions were found in 93% of patients during a
second procedure.57 Complications associated with adhesions are
small bowel obstruction (SBO),58 chronic pelvic pain,59 infertility,60
and the risk of inadvertent bowel injuries in subsequent pro-
cedures.61 A recent review of 2000 laparoscopies conducted for the
treatment of acute SBO, declared that adhesions were accountable
for 84.9% of the small bowel obstructions.62 Although adhesions are
described as an important cause of chronic pelvic pain, its real
impact remains controversial.59 One further major concern about
adhesions is the unfavorable inﬂuence that they could have on
future fertility. Adhesions can lead to an impaired interaction be-
tween the Fallopian tube and the ovary and it is assumed that ad-
hesions cause 20e40% of female infertility.63,64 It is known that
some gynecological procedures carry a higher risk of adhesion
development than others65 whereas myomectomy is associated
with a high risk for adhesion formation.66 Bearing this in mind, it is
important to ﬁnd ways to reduce adhesion formation after myo-
mectomy, as this procedure is often performed to restore child-
bearing potential.
Conﬂicting data exists when comparing laparoscopy and lapa-
rotomy in their adhesiogenic potential. Although laparoscopy was
long regarded to be less adhesiogen, it was demonstrated that the
laparoscopic environment itself functions as a cofactor in adhesion
formation. The pressure used to maintain the pneumoperitoneum
leads to tissue hypoxia and thereby to alterations in the ﬁbrino-
lytic system which is a key factor in adhesion formation.
Furthermore, the use of cold and dry insufﬂation gas could lead to
peritoneal damage through tissue desiccation, although tissue
desiccation is also a problem during open surgery.67 Nevertheless,studies investigating adhesion formation after myomectomy by
laparoscopy or laparotomy revealed that adhesions occur less
often after laparoscopy. The published incidence of adhesions after
myomectomy varies as shown by the following studies. In a pro-
spective blinded observational study Tinelli et al68 investigated the
effect of an antiadhesion agent after both laparoscopic myomec-
tomy and abdominal myomectomy. A large number of patients
(n ¼ 546) with comparable baseline characteristics and no dif-
ference in the dimension of the ﬁbroid were assessed during a
second procedure conducted for several reasons. The incidence of
adhesions in the different groups was as follows: abdominal
myomectomy (AM) without adhesion barrier (AB; 28.1%), laparo-
scopic myomectomy (LM) without AB (22.6%), AM with AB (22%),
and LM with AB (15.9%). Kubinova et al69 assessed adhesions
during a second-look laparoscopy for adhesiolysis after abdominal
or laparoscopic myomectomy. In their study, 96.65% of patients
had adhesions after laparotomy (n ¼ 28) compared with 71.43% of
patients after laparoscopy (n ¼ 68). If adhesions were present,
patients after abdominal myomectomy had more dense adhesions
than patients after laparoscopy. Furthermore, after abdominal
myomectomy 89.29% of patients had de novo adnexal adhesions
which might compromise fertility. In the laparoscopic group de
novo adnexal adhesions were observed in 10.6% of patients.
Another study also assessed the occurrence of adhesions after
laparoscopic myomectomy during a second procedure and found
adhesions in only 1.6% of patients (2/121).70 Although the use of
laparoscopy is not able to prevent adhesion formation completely,
it can be shown that the occurrence of adhesions is reduced after
laparoscopy.
Several factors associated with myomectomy inﬂuence the for-
mation of adhesions. Some studies revealed that myomas of the
posterior uterine site lead to more adhesions than fundal or ante-
rior myomas.71,72 Further inﬂuencing factors are the size and the
number of removed myomas.73 Suturing of the uterine surface can
increase the risk of adhesion formation.74e76 Furthermore, the skill
of the surgeon may also have an impact on the development of
adhesions.73 Thus, following the principles of gentle tissue
handling is important to avoid extensive trauma to the peritoneum
which could result in adhesions. These principles include constant
tissue moistening and reduced use of electrocautery.77 In addition,
in high risk procedures like myomectomy, the use of an anti-
adhesion agent should be considered.78
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The role of ﬁbroids as a cause for infertility, is still controversial.
There is agreement that large submucosal ﬁbroids are associated
with increased miscarriage rate and reduced fertility, and that
removal of submucosal ﬁbroids improve fertility outcomes. As
submucosal myomas are mainly removed hysteroscopically, they
are not included in this article.79 Whereas subserosal ﬁbroids seem
to have no impact on fertility, there is conﬂicting evidence on the
impact of intramural ﬁbroids on fertility.80 In a recent systematic
review, the implantation rate and the ongoing pregnancy rate were
found to be signiﬁcantly lower in the presence of intramural ﬁ-
broids, whereas the spontaneous abortion rate was signiﬁcantly
higher.81 These datawere obtained only during prospective trials. A
further restriction to studies, which used a high-quality method to
assess the uterine cavity, revealed that the implantation rate was
still signiﬁcantly impaired, but the other parameters do not reach
signiﬁcance. Moreover, advising infertile patients with intramural
ﬁbroids on surgery is controversial due to limited data on the
impact of myomectomy on improving fertility.81 Somigliana et al82
proposed to make the decision for surgery based on: “(i) the age of
thewoman; (ii) the location, dimension and number of the ﬁbroids;
(iii) the concomitant presence of ﬁbroid-related symptoms such as
menorrhagia or hypermenorrhea; and (iv) the presence of other
causes of infertility and whether or not there is an indication to
IVF”.
If surgery is recommended, the best approach has to be chosen
for the patient not to further compromise fertility. Additionally, not
all myomectomies conducted in women of childbearing age are
performed in infertile patients. Because more and more women
decide to postpone their childbearing to a later age, myomectomies
are frequently performed in symptomatic patients with a desire for
subsequent pregnancies.83 Hence, it is important to decide which
the best approach is, for both infertility and symptomatic patients,
to improve fertility outcomes. At present, only two randomized
controlled trials are available comparing fertility outcomes after
laparoscopic and abdominal myomectomy.37,47 Seracchioli et al37
investigated 131 patients with otherwise unexplained infertility
and found no signiﬁcant differences in the pregnancy and abortion
rate between the two groups. However, patients in the laparoscopic
group showed better short-term outcomes (Table 1). A more recent
study by Palomba et al47 investigated the reproductive outcomes in
both infertility and symptomatic patients (n ¼ 136). In the case of
infertility, no difference in the cumulative pregnancy rate, abortion
rate, and live-birth rate between laparoscopy and minilaparotomy
was found. The authors stated that the study was probably un-
derpowered to demonstrate a signiﬁcant difference. Comparing
only patients with myomectomy for symptomatic myomas, how-
ever, cumulative pregnancy rate, pregnancy rate per cycle, and live-
birth rate per cycle were signiﬁcantly higher in the laparoscopic
group. Furthermore, the time to ﬁrst pregnancy and live-birth was
signiﬁcantly lower after laparoscopic myomectomy.47 Thus, lapa-
roscopy performed for the removal of symptomatic myomas may
not only have advantages in short-term outcomes, but also in
fertility outcomes. In the future, large-scaled, prospective, ran-
domized studies are needed to conﬁrm these ﬁndings.
Uterine rupture
The main concern after laparoscopic myomectomy in women of
childbearing age regards the strength of the myomectomy scar
during subsequent pregnancies. Although it seems to be a rare
event, reports of uterine rupture after abdominal myomectomy also
exist in the literature.84e86 However, pregnancies after laparoscopic
myomectomy have been a matter of concern because laparoscopicsuturing is regarded as a demanding task. Several factors may
contribute to the development of a weak scar with the subsequent
risk for uterine rupture. The extensive use of electrocoagulation
instead of sutures to achieve hemostasis can lead to tissue necrosis
followed by an impaired wound healing.87 Furthermore, the pres-
ence of infection or hematoma formation within the myometrium,
the extent of local tissue destruction, and individual healing char-
acteristics are also factors which could inﬂuence wound healing in
the myometrium.88 Another important contributing factor to the
development of a weak scar may be an inadequate suturing of the
myometrial defect. A recent review of 19 case reports of uterine
rupture after laparoscopic myomectomy revealed that in seven
cases the uterine defect was not repaired (3 subserosal myomas and
4 subserosal pedunculated myomas), in three cases it was repaired
with a single suture (1 subserosal myoma and 2 intramural my-
omas), in four cases it was repaired in only one layer (intramural
myomas), and in one case only the serosa was closed (subserosal
myoma).88 Depending on the depth of the myometrial defect, a
multilayer closure may be necessary to eliminate dead space and to
achieve an adequate wound closure.87,89
Considering several studies on fertility outcome after laparo-
scopic myomectomy, uterine rupture seems to be also a rare event
after laparoscopy.23 A large review including 626 pregnancies after
laparoscopic myomectomy found only one case of uterine
rupture.23 In the above-mentioned review of case reports, time of
uterine rupture range from 17 weeks to 40 weeks of gestation.88
Thus, the possibility of uterine rupture should already be taken
into consideration prior to the start of labor and patients should be
appropriately counseled. Additionally, the mode of delivery, vagi-
nally or by cesarean section, must be discussed with the patients.
Kumakiri et al89 prospectively investigated the safety of vaginal
birth after laparoscopic myomectomy by using the criteria for a
vaginal birth after cesarean section. The authors concluded that in
selected patients vaginal delivery could be successfully accom-
plished if the myomectomy wound is appropriately sutured.
Therefore, pregnancies after laparoscopic myomectomy carry a low
risk of uterine rupture if laparoscopy is conducted by a surgeonwho
has sufﬁcient expertise.
Myoma recurrence
The risk for myoma recurrence after laparoscopic myomectomy
compared with abdominal myomectomy is still a matter of debate.
It is assumed that the inability to palpate the uterus during lapa-
roscopy leads to a higher recurrence rate due to small intramural
myomas which are left behind in the uterus. These myomas could
grow and could be responsible for the recurrence of symptoms.90
The 5-year cumulative recurrence rate after laparotomy varies
from 5.7% to 11.1% if the recurrence rate is not assessed through
systematic ultrasound investigations [90].90 If transvaginal ultra-
sonography is used, the recurrence rate after abdominal myomec-
tomy is much higher and varies from 15.4% to 62%.90e92In their
study, Nezhat et al revealed a 5-year cumulative recurrence rate
after laparoscopic myomectomy of 51.4% evaluated through chart
reviews, returned questionnaires, and telephone interviews. The
authors concluded that the recurrence rate after laparoscopy may
be higher than reported after laparotomy.93,94 In a prospective,
randomized study, the recurrence rate between abdominal and
laparoscopic myomectomy was compared in 81 patients. Trans-
vaginal ultrasonography was used for assessment and after a study
period of 40 months, the recurrence rates were similar in both
groups (27% laparoscopy and 23% laparotomy, respectively).
Furthermore, in this study, none of the women with myoma
recurrence required additional surgery during the study period.95
In another large study, investigating 512 patients who underwent
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years and at 8 years was 52.9% and 84.4%, respectively, whereas the
cumulative probability of reoperation for recurrent myoma was
6.7% at 5 years and 16% at 8 years, respectively.96 Factors inﬂu-
encing myoma recurrence may be age, number of myomas, uterine
size, and childbirth after myomectomy,90,91,96 although other au-
thors did not ﬁnd a relationship between these factors and myoma
recurrence.95 However, further longerm, prospective, randomized
studies are needed to compare the recurrence rate after laparo-
scopic and abdominal myomectomy including skill factors. More-
over, it is important to evaluate the clinical impact of myoma
recurrence, measured through the need for subsequent treatment,
as well as the inﬂuencing factors. Thus, patients should be appro-
priately counselled about probability and risk factors for myoma
recurrence.
Training and uptake of laparoscopic myomectomy
Despite the above-mentioned advantages of laparoscopic myo-
mectomy, abdominal myomectomy is still a frequently performed
procedure. In France, 37,787 patients required an intervention for
uterine myomas in 2005. The study data were obtained through
analysis of a national hospital activity database. Treatment of my-
omas included 22,540 (59.7%) hysterectomies, 6291 hysteroscopic
resections, and 571 UAEs. A total of 8385 myomectomies were
conducted including 2277 laparoscopic and 6108 abdominal myo-
mectomies.97 In Germany, hospital admissions due to interventions
for uterine myomas were identiﬁed through DRG (diagnosis-
related group) codes. In 2005, 64,299 patients were admitted for
uterine myomas. 54,577 (84.9%) patients were treated with hys-
terectomy and in 1527 patients the myoma were removed through
hysteroscopic resection. A total of 8195 myomectomies were con-
ducted including 315 vaginal myomectomies, 4692 laparoscopic
myomectomies, and 3188 abdominal myomectomies (including
504 laparoconversions). In Germany, more laparoscopic than
abdominal myomectomies were performed, although the number
of conducted laparotomies was still high.97 Because acquiring
laparoscopic skills is more challenging than acquiring skills needed
for conduction of open surgery, not all surgeons are able to perform
advanced laparoscopic procedures such as myomectomy.98 A UK
survey, published in 2006, revealed that only 11% of the re-
spondents perform laparoscopic myomectomy (response rate
59%).99 In a recent Canadian survey, 24.5% of the respondents
perform laparoscopic myomectomy and 3.1% stated that more than
50% of their myomectomies are conducted laparoscopically. These
rates might be overestimated as the response rate was only 41.4%
and it is likely that the questionnaires were answered by gyne-
cologists who were interested in the topic or perform laparoscopic
myomectomy. According to this survey, the main obstacle to per-
forming laparoscopic myomectomy was the lack of training in the
procedure (70.7% of respondents).100 During residency, only a few
residents have the opportunity to gain practical experience in
advanced laparoscopic procedures such as myomectomy.101 How-
ever, for the implementation of laparoscopy, training of basic
laparoscopic skills during residency is also important, as laparos-
copies are performed by surgeons who received explicit training
during residency.102 It was shown that simulator training can be an
effective tool to enhance basic laparoscopic skills leading to a better
performance during future procedures.103 After ﬁnishing residency,
acquirement of advanced laparoscopic skills can be difﬁcult if there
is no opportunity for appropriate teaching and training. Hiring an
experienced laparoscopic surgeon who is interested in teaching
other surgeons, in combination with surgeons who are interested
in learning advanced laparoscopic procedures, has proven to be an
effective method to implement advanced laparoscopic proceduresinto daily practice.102,104 Although not all surgeons are similarly
skilled,105 personal efforts should be made by every surgeon who
performs laparoscopy to continuously enhance personal laparo-
scopic skills, and thereby enhance the safety of patients. As Sami
Walid106 recently mentioned: “gynecologists need to improve their
laparoscopic skills, as minimally invasive surgery is becoming the
sine qua non of a modern surgeon”. In the future, it is likely that
there will be a steadily increasing demand for minimally invasive
procedures by patients.100 Thus, if the patient is a candidate for
laparoscopic myomectomy, the procedure should be offered to the
patient, either performed personally or through referral to an
experienced colleague, for providing the best care.
Cost considerations
One frequently mentioned concern about laparoscopic myo-
mectomy is the expected higher costs associated with laparoscopic
procedures. A review of studies comparing abdominal and laparo-
scopic hysterectomies demonstrated that although laparoscopy
was associated with higher direct costs, the indirect costs were
lower and might compensate the higher direct costs.107 At present,
studies comparing the costs of abdominal and laparoscopic myo-
mectomy are sparse. In a recent study, abdominal myomectomy
was the least expensive approach compared with robotic-assisted
laparoscopic myomectomy.56 Contrarily, in another study, no sig-
niﬁcant difference in the average costs of abdominal and laparo-
scopic myomectomy was found.34 Thus, further studies are needed
to compare costs of the procedures, including indirect costs as well
as long-term costs if additional treatment is required.
Conclusion
Laparoscopic myomectomy has several advantages over
abdominal myomectomy and even over myomectomy by mini-
laparotomy, given that minilaparotomy is suggested as a minimally
invasive alternative to laparotomy. These advantages include a
lower decline in hemoglobin concentrations, lower postoperative
pain, lower analgesic requirements, a shorter hospital stay, and a
faster postoperative recovery (Tables 1 and 2). Moreover, myo-
mectomy by laparoscopy decreases the risk of adhesion formation
which could potentially lead to serious complications. Compared
with abdominal myomectomy, fertility outcomes in infertile pa-
tients seem to be similar after laparoscopy, whereas in symptom-
atic patients, laparoscopy may lead to higher pregnancy rates.
Furthermore, if the procedures are performed by a surgeon who is
skilled in laparoscopic surgery, uterine ruptures after laparoscopic
myomectomies are rare events. Therefore, laparoscopy should be
the standard approach for myomectomy. Nevertheless, further
prospective, randomized studies are needed to compare long-term
outcomes between different invasive and noninvasive treatment
options in uterine myomas including skill evaluation.
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